Espinoza-Hernández JD

Idioma: Ingles.
Referencias bibliográficas: 5
Paginas: 74-75
Archivo PDF: 121.71 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Fearon WF, Zimmermann FM, De Bruyne B, et al; FAME 3 Investigators. FractionalFlow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. NEngl J Med. 2022;386(2):128-137. doi: 10.1056/NEJMoa2112299.

2. Fearon WF, Zimmermann FM, Ding VY, et al; FAME 3 Investigators. Quality ofLife After Fractional Flow Reserve-Guided PCI Compared with Coronary BypassSurgery. Circulation. 2022;145(22):1655-1662. doi: 10.1161/CIRCULATIONAHA.122.060049.

3. Rodriguez A, Boullon F, Perez-Baliño N, Paviotti C, Liprandi MI, Palacios IF.Argentine randomized trial of percutaneous transluminal coronary angioplastyversus coronary artery bypass surgery in multivessel disease (ERACI): in-hospitalresults and 1-year follow-up. ERACI Group. J Am Coll Cardiol. 1993;22(4):1060-7. doi: 10.1016/0735-1097(93)90416-x.

4. Cohen DJ, Van Hout B, Serruys PW, et al; Synergy between PCI with Taxus andCardiac Surgery Investigators. Quality of life after PCI with drug-eluting stentsor coronary-artery bypass surgery. N Engl J Med. 2011;364(11):1016-26. doi:10.1056/NEJMoa1001508.

5. Weintraub WS; Grau-Sepulveda MV; Weiss JM; O’Brien SM; Peterson ED, et.al.Comparative Effectiveness of Revascularization Strategies. N Engl J Med 2012;366:1467-76. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparativeeffectiveness of revascularization strategies. N Engl J Med. 2012;366(16):1467-76. doi: 10.1056/NEJMoa1110717.